Phospho-Rad17 (Ser645) Antibody [D14D16]

Catalog No.: F6403

Application: Reactivity: Human

Lane 1: Hela, Lane 2: Hela (CIP and λ phosphatase treated)

当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

代表番号: 045-509-1970|電子メール：sales@selleck.co.jp

使用情報

Dilution
WB1:1000 IP1:200

Application
WB, IP

Source
Rabbit Monoclonal Antibody

Reactivity
Human

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
80 kDa

Datasheet & SDS

生物学的記述

Specificity
Phospho-Rad17 (Ser645) Antibody [D14D16] detects endogenous levels of total Rad17 protein only when it is phosphorylated at Ser645.

Clone
D14D16

Synonym(s)
Cell cycle checkpoint protein RAD17; RAD17

Background
Phospho-Rad17 at Ser645 represents the activated form of the Rad17 checkpoint protein within the RFC-like clamp loader family, critical for sensing DNA damage and replication stress to enforce cell cycle arrest. The protein maintains a toroidal structure analogous to replication factor C, with distinct AAA+ ATPase domains that facilitate interaction with the Rad9-Rad1-Hus1 (9-1-1) sliding clamp and recruitment to chromatin at ssDNA-dsDNA junctions via ATRIP-RPA recognition. Upon genotoxic insult from ionizing radiation or replication inhibitors, ATR kinase targets the SQ motif at Ser645 for phosphorylation through a two-step process where pre-bound Rad17 captures the 9-1-1 complex, amplifying local ATR activity and enabling phospho-Ser645-dependent conformational shifts that stabilize clamp loading and propagate downstream signaling. This modification licenses Rad17 to scaffold the MRN complex (MRE11-RAD50-NBS1) at double-strand breaks, channeling ATM/ATR activation toward CHK1/CHK2 phosphorylation cascades that halt S-phase progression and G2/M transition via Cdc25 inactivation. Phospho-Ser645 peaks in late G1 through G2/M during unperturbed replication but surges rapidly in early G1 under damage, reflecting cell cycle-regulated basal priming overlaid with inducible ATR/ATM responses. Mutation to alanine at Ser645 alongside Ser635 abolishes G1/S and G2 checkpoint enforcement, rendering cells hypersensitive to clastogens and replication toxins. ATM-deficient contexts sustain Ser645 phosphorylation albeit suboptimally, underscoring ATR dominance in this event.

Background

Phospho-Rad17 at Ser645 represents the activated form of the Rad17 checkpoint protein within the RFC-like clamp loader family, critical for sensing DNA damage and replication stress to enforce cell cycle arrest. The protein maintains a toroidal structure analogous to replication factor C, with distinct AAA+ ATPase domains that facilitate interaction with the Rad9-Rad1-Hus1 (9-1-1) sliding clamp and recruitment to chromatin at ssDNA-dsDNA junctions via ATRIP-RPA recognition. Upon genotoxic insult from ionizing radiation or replication inhibitors, ATR kinase targets the SQ motif at Ser645 for phosphorylation through a two-step process where pre-bound Rad17 captures the 9-1-1 complex, amplifying local ATR activity and enabling phospho-Ser645-dependent conformational shifts that stabilize clamp loading and propagate downstream signaling. This modification licenses Rad17 to scaffold the MRN complex (MRE11-RAD50-NBS1) at double-strand breaks, channeling ATM/ATR activation toward CHK1/CHK2 phosphorylation cascades that halt S-phase progression and G2/M transition via Cdc25 inactivation. Phospho-Ser645 peaks in late G1 through G2/M during unperturbed replication but surges rapidly in early G1 under damage, reflecting cell cycle-regulated basal priming overlaid with inducible ATR/ATM responses. Mutation to alanine at Ser645 alongside Ser635 abolishes G1/S and G2 checkpoint enforcement, rendering cells hypersensitive to clastogens and replication toxins. ATM-deficient contexts sustain Ser645 phosphorylation albeit suboptimally, underscoring ATR dominance in this event.

References
[1] Post S, et al. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13102-7. [2] Bao S, et al. Nature. 2001 Jun 21;411(6840):969-74.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%